Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title:Preface
Volume: 18 Issue: 1
Author(s): Simone Carradori
Affiliation:
Export Options
About this article
Cite this article as:
Carradori Simone , Preface, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2019; 18 (1) . https://dx.doi.org/10.2174/187152301801190206113419
DOI https://dx.doi.org/10.2174/187152301801190206113419 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
42
1
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Vitamin D status in coronary artery disease: association with IL-35 and TGF-β1 and disease severity
Endocrine, Metabolic & Immune Disorders - Drug Targets Targeting Histone Deacetylases for the Treatment of Immune, Endocrine & Metabolic Disorders
Endocrine, Metabolic & Immune Disorders - Drug Targets The Therapeutic Potential of Fungal Ribotoxins
Current Pharmaceutical Biotechnology Action Mechanisms of Chinese Herbal Compound at the Molecular Level
Letters in Drug Design & Discovery Anticancer Effect and Phytochemical Profile of the Extract from <i>Achillea ketenoglui</i> against Human Colorectal Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Interferon-Beta Injection in Multiple Sclerosis Patients Related to the Induction of Headache and Flu-Like Pain Symptoms: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Current Neuropharmacology MicroRNAs: Regulators of TLR2-Mediated Probiotic Immune Responses
MicroRNA Identification of Immunogenic MHC Class II Tyrosinase-Derived Peptides Using HLA-DR1 and HLA-DR4 Transgenic Mice
Protein & Peptide Letters Attenuation of ERK/RSK2-Driven NFκB Gene Expression and Cancer Cell Proliferation by Kurarinone, a Lavandulyl Flavanone Isolated from Sophora flavescens Ait. Roots
Endocrine, Metabolic & Immune Disorders - Drug Targets Modulation of the Immune System for the Treatment of Glaucoma
Current Neuropharmacology Synthesis and Evaluation of Transdermal Permeation, Pharmacological Activity of Bornyl NSAID Esters
Letters in Drug Design & Discovery Childhood Alopecia Areata: An Overview of Treatment and Recent Patents
Recent Patents on Inflammation & Allergy Drug Discovery The Study of Marketed and Experimental Formulation Approaches Enabling Site-specific Delivery of Mesalamine in Patients with Inflammatory Bowel Disease
Recent Patents on Drug Delivery & Formulation Modulation of Cardiac and Hepatic Cytochrome P450 Enzymes During Heart Failure
Current Drug Metabolism Immune Mechanisms and Related Targets for the Treatment of Fibrosis in Various Organs
Current Molecular Medicine Heparan Sulphate Proteoglycans and Viral Vectors : Ally or Foe?
Current Gene Therapy Is There Any Role of IL-6 Inhibition in COVID-19?
Coronaviruses NSAID Acyl Glucuronides and Enteropathy
Current Drug Metabolism Propitious Profile of Peppery Piperine
Current Molecular Pharmacology Zevalin™: 90Yttrium Labeled Anti-CD20 (Ibritumomab Tiuxetan), a New Treatment for Non-Hodgkin ’ s Lymphoma
Current Pharmaceutical Biotechnology